PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,515,000 | +15.2% | 326,593 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $1,315,000 | -66.5% | 313,104 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $3,926,000 | +9.5% | 626,208 | +40.4% | 0.00% | -50.0% |
| Q2 2018 | $3,586,000 | +45.9% | 445,987 | +35.3% | 0.00% | 0.0% |
| Q1 2018 | $2,458,000 | +23.1% | 329,537 | -1.8% | 0.00% | +100.0% |
| Q4 2017 | $1,997,000 | -42.7% | 335,583 | -29.2% | 0.00% | -50.0% |
| Q3 2017 | $3,488,000 | +81.6% | 473,884 | +67.5% | 0.00% | +100.0% |
| Q2 2017 | $1,921,000 | +6.2% | 282,978 | +47.7% | 0.00% | 0.0% |
| Q1 2017 | $1,808,000 | +3.4% | 191,541 | -5.4% | 0.00% | 0.0% |
| Q4 2016 | $1,749,000 | -4.7% | 202,438 | -30.2% | 0.00% | 0.0% |
| Q3 2016 | $1,835,000 | +67.3% | 289,956 | +11.5% | 0.00% | 0.0% |
| Q2 2016 | $1,097,000 | +17.0% | 259,972 | +20.8% | 0.00% | 0.0% |
| Q1 2016 | $938,000 | -32.4% | 215,175 | -5.0% | 0.00% | 0.0% |
| Q4 2015 | $1,388,000 | -2.9% | 226,400 | -9.4% | 0.00% | 0.0% |
| Q3 2015 | $1,429,000 | -20.6% | 249,849 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $1,800,000 | +9.4% | 241,240 | -12.4% | 0.00% | 0.0% |
| Q1 2015 | $1,646,000 | -19.0% | 275,248 | +2.5% | 0.00% | 0.0% |
| Q4 2014 | $2,031,000 | +32.7% | 268,640 | -8.9% | 0.00% | 0.0% |
| Q3 2014 | $1,531,000 | +16.7% | 294,924 | -3.1% | 0.00% | 0.0% |
| Q2 2014 | $1,312,000 | +42.6% | 304,501 | +35.3% | 0.00% | 0.0% |
| Q1 2014 | $920,000 | -25.5% | 224,996 | -2.9% | 0.00% | 0.0% |
| Q4 2013 | $1,235,000 | +5.9% | 231,796 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,166,000 | +37.5% | 231,796 | +22.0% | 0.00% | 0.0% |
| Q2 2013 | $848,000 | – | 190,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|